Kerry to host meeting between FDA reps and industry; J&J filing reveals Synthes deal details;

> Sen. John Kerry (D-MA) is making some moves to protect one of his major business constituencies in the Bay State. He will host a pair of meetings in Boston on July 11 between FDA commissioner Margaret Hamburg, CDRH chief Dr. Jeffrey Shuren and representatives from the Commonwealth's medical device and biotechnology industries in an effort to open up a dialogue between the oversight bureau and two of the state's most critical industries. News

> Synthes solicited bids from 9 companies and then 6 private equity firms before agreeing to be bought by Johnson & Johnson for $21.3 billion, according to a J&J filing with the SEC. Item

> Stryker Joint Preservation announced has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's RegenKit-THT, a one-step system designed for the safe and rapid preparation of autologous platelet-rich plasma from a small sample of blood at the patient's point of care. Stryker also added its inflatable vertebral augmentation system  to its national agreement with supply contracting company Novation. Stryker release | Story

> TearScience has won FDA clearance for its LipiFlow system used to diagnose and treat a common form of dry-eye disease. It's a major milestone for the company, which plans to hire up to a dozen more people to handle sales and customer service. Report

> Boston Scientific is looking to hire 250 new employees in the area of engineering, production, quality control and processes development. The hiring is due to the expansion of the firms Global Park centre located in Heredia. Item

And Finally... A California woman has pleaded guilty to creating sham companies that sold non-existent merchandise to Medtronic, defrauding the company out of millions of dollars. Jennifer Rutherford pleaded guilty to one count of wire fraud in connection to the crime. In her plea agreement, Rutherford admitted orchestrating the scheme between June 2004 and June 2009. U.S. Attorney release

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.